VEGF-B signaling impairs endothelial glucose transcytosis by decreasing membrane cholesterol content.
Christine MoessingerIngrid NilssonLars MuhlManuel ZeitelhoferBenjamin Heller SahlgrenJosefin SkogsbergUlf ErikssonPublished in: EMBO reports (2020)
Regulation of endothelial nutrient transport is poorly understood. Vascular endothelial growth factor B (VEGF-B) signaling in endothelial cells promotes uptake and transcytosis of fatty acids from the bloodstream to the underlying tissue, advancing pathological lipid accumulation and lipotoxicity in diabetic complications. Here, we demonstrate that VEGF-B limits endothelial glucose transport independent of fatty acid uptake. Specifically, VEGF-B signaling impairs recycling of low-density lipoprotein receptor (LDLR) to the plasma membrane, leading to reduced cholesterol uptake and membrane cholesterol loading. Reduced cholesterol levels in the membrane leads to a decrease in glucose transporter 1 (GLUT1)-dependent endothelial glucose uptake. Inhibiting VEGF-B in vivo reconstitutes membrane cholesterol levels and restores glucose uptake, which is of particular relevance for conditions involving insulin resistance and diabetic complications. In summary, our study reveals a mechanism whereby VEGF-B regulates endothelial nutrient uptake and highlights the impact of membrane cholesterol for regulation of endothelial glucose transport.
Keyphrases
- endothelial cells
- low density lipoprotein
- vascular endothelial growth factor
- fatty acid
- high glucose
- blood glucose
- type diabetes
- insulin resistance
- blood brain barrier
- signaling pathway
- blood pressure
- polycystic ovary syndrome
- wound healing
- escherichia coli
- skeletal muscle
- klebsiella pneumoniae
- glycemic control
- multidrug resistant